Lee Sung
SEC CIK 1793200 · EDGAR
BoughtSold
Most active insiders at CYTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| 2 | Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| 3 | Lee Sung | EVP, CFO | — | $5.70M |
| 4 | Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| 5 | Kaye Edward M. MD | Dir | — | $3.21M |
| 6 | HENDERSON JOHN T | Dir | — | $2.08M |
| 7 | WIERENGA WENDELL | Dir | — | $1.88M |
| 8 | PARSHALL B LYNNE | Dir | — | $1.36M |
| 9 | Landry Robert E | Dir | — | $146.8K |
| 10 | Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-02 17:17 | 2026-07-01 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | M - OptEx | $48.51 | +1,112 | 64.3K | +2% | +$53.9K |
| DT | 2026-07-02 17:17 | 2026-07-01 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | S - Sale+OE | $87.79 | -1,112 | 63.2K | -2% | -$97.6K |
| DMT | 2026-06-29 18:05 | 2026-06-24 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | M - OptEx | $47.10 | +38.7K | 102.0K | +61% | +$1.82M |
| DT | 2026-06-29 18:05 | 2026-06-24 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | S - Sale+OE | $82.30 | -38.7K | 63.2K | -38% | -$3.19M |
| DMT | 2026-06-29 17:23 | 2026-06-29 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | M - OptEx | $45.83 | +3,134 | 66.4K | +5% | +$143.6K |
| DT | 2026-06-29 17:23 | 2026-06-29 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | S - Sale+OE | $85.00 | -3,134 | 63.2K | -5% | -$266.4K |
| D | 2026-06-08 17:49 | 2026-06-05 | TNGX | Tango Therapeutics, Inc. | Lee Sung | Dir | A - Grant | $0.00 | +570 | 22.9K | +3% | $0 |
| T | 2026-05-05 16:18 | 2026-05-05 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | S - Sale | $76.87 | -23.9K | 63.2K | -27% | -$1.84M |
| D | 2026-05-01 17:26 | 2026-04-29 | TNGX | Tango Therapeutics, Inc. | Lee Sung | Dir | A - Grant | $0.00 | +12.3K | 22.3K | +123% | $0 |
| 2026-03-18 | 2026-03-17 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | S - Sale | $62.15 | -4,935 | 87.1K | -5% | -$306.7K | |
| D | 2026-03-17 | 2026-03-15 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | A - Grant | $0.00 | +20.6K | 92.1K | +29% | $0 |
| D | 2026-01-06 | 2026-01-02 | TNGX | Tango Therapeutics, Inc. | Lee Sung | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
| M | 2025-12-29 | 2025-12-22 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | A - Grant | $0.00 | +4,304 | 72.2K | +6% | $0 |
| 2025-12-29 | 2025-12-22 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | F - Tax | $62.72 | -805 | 71.4K | -1% | -$50.5K | |
| 2025-12-05 | 2025-12-03 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | F - Tax | $65.02 | -1,560 | 67.9K | -2% | -$101.4K | |
| 2025-06-03 | 2025-06-02 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | F - Tax | $31.21 | -4,965 | 69.5K | -7% | -$155.0K | |
| D | 2025-03-18 | 2025-03-14 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | A - Grant | $0.00 | +32.7K | 74.4K | +78% | $0 |
| M | 2024-12-05 | 2024-12-03 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | A - Grant | $0.00 | +8,607 | 39.0K | +28% | $0 |
| 2024-12-05 | 2024-12-03 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | F - Tax | $51.51 | -1,536 | 37.5K | -4% | -$79.1K | |
| D | 2024-06-03 | 2024-05-31 | CYTK | CYTOKINETICS INC | Lee Sung | EVP, CFO | A - Grant | $0.00 | +34.7K | 34.7K | New | $0 |
| 2024-03-28 | 2024-03-27 | VIR | Vir Biotechnology, Inc. | Lee Sung | EVP, CFO | S - Sale | $9.89 | -6,008 | 100.5K | -6% | -$59.4K | |
| D | 2024-02-26 | 2024-02-22 | VIR | Vir Biotechnology, Inc. | Lee Sung | EVP, CFO | A - Grant | $0.00 | +40.0K | 106.5K | +60% | $0 |
| D | 2023-03-29 | 2023-03-27 | VIR | Vir Biotechnology, Inc. | Lee Sung | CFO | A - Grant | $0.00 | +66.5K | 66.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations